Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Astellas, MD Anderson: Agreement to Research, Develop AML Treatment

April 6, 2015 9:59 am | News | Comments

Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center today announced the signing of an option agreement to research and develop a new treatment for patients with acute myeloid leukemia (AML). Read more...

TOPICS:

From the Heart

April 6, 2015 9:53 am | by Anne Trafton, MIT | News | Comments

​Laurie Boyer’s studies of stem cell differentiation could improve treatments for heart disease. Read more...

TOPICS:

Personalized Melanoma Vaccines Marshal Immune Response

April 6, 2015 9:49 am | by Washington University in St. Louis | News | Comments

Personalized melanoma vaccines can be used to marshal a powerful immune response against unique mutations in patients’ tumors, according to early data in a first-in-people clinical trial at Washington University School of Medicine in St. Louis. Read more...

TOPICS:
Advertisement

Dallas Hospital Seeks Dismissal of Nurse's Suit Over Ebola

April 6, 2015 9:40 am | by Associated Press | News | Comments

A hospital operator denied allegations of poor training and improper preparation in seeking dismissal of a lawsuit by a nurse who contracted Ebola while caring for the first U.S. patient to succumb to the deadly disease. Read more...

TOPICS:

Saving Lives by Making Malaria Drugs More Affordable

April 6, 2015 8:34 am | by UC Berkeley | News | Comments

New research determines that the “shelf life” of malaria-fighting drugs plays a significant role in how donors should subsidize the medicine in order to ensure better affordability for patients. Read more...

TOPICS:

NTU Finds New Treatment Options for Colon Cancer

April 6, 2015 8:30 am | by Nanyang Technological University | News | Comments

Scientists have discovered that an existing chemotherapy drug used to treat leukaemia could prevent and control the growth of colorectal tumors. Read more...

TOPICS:

Teva Announces FDA Approval of ProAir RespiClick

April 6, 2015 8:17 am | News | Comments

It's the first SABA inhaler to be approved by the FDA. Read more...

TOPICS:

GSK to Establish Global Vaccines R&D Center in the U.S.

April 6, 2015 8:17 am | News | Comments

GSK announced it is further strengthening and expanding its vaccines presence in the US by establishing a new global centre for vaccines research and development in Rockville, Maryland. Read more...

TOPICS:
Advertisement

Imported Drug-Resistant Stomach Bug Spreading in U.S.

April 6, 2015 8:16 am | by Mike Stobbe, AP Medical Writer | News | Comments

A drug-resistant strain of a nasty stomach bug made its way into the U.S. and spread, causing more than 200 illnesses since last May. Read more...

TOPICS:

Pfizer Stops China Vaccine Sales as Import License Expires

April 6, 2015 8:16 am | by The Associated Press | News | Comments

The world's second-biggest drugmaker by revenue said that it stopped sales immediately, a decision that affected about 200 of Pfizer's 9,000 employees in China. Read more...

TOPICS:

New Sickle Cell Gene Therapy Approaches

April 2, 2015 11:21 am | by Cynthia Fox, Science Writer | Articles | Comments

As a patient prepares to become the first in history to receive his own genetically engineered stem cells for sickle cell disease, two top scientists are already improving the approach. Read more...

TOPICS:

New Knowledge EphB Signaling May Improve Intestinal Cancers' Treatment

April 2, 2015 10:41 am | by Karolinska Institutet | News | Comments

A new study led by researchers at Sweden's Karolinska Institutet and Nanyang Technological University in Singapore, provides experimental evidence that a drug that inhibits the EphB-signaling pathway in the cell effectively can suppress the development of intestinal tumors. Read more..

TOPICS:

Experimental Ebola Vaccine Appears Safe, Prompts Immune Response

April 2, 2015 10:35 am | by NIH | News | Comments

An early-stage clinical trial of an experimental Ebola vaccine conducted at the National Institutes of Health (NIH) and the Walter Reed Army Institute of Research (WRAIR) found that the vaccine, called VSV-ZEBOV, was safe and elicited robust antibody responses in all 40 of the healthy adults who received it. Read more...

TOPICS:

Teva Pharmaceutical Buys Auspex for $3.2B

April 2, 2015 9:35 am | by The Associated Press | News | Comments

Teva is one of the world's largest generic drug developers. Read more...

TOPICS:

Valeant Pharmaceuticals Completes Salix Acquisition

April 2, 2015 9:30 am | News | Comments

Valeant Pharmaceuticals announced it has completed the previously announced acquisition of Salix Pharmaceuticals. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading